3D Ready Organoid Expansion Service
Expansion of organoids at scale using our patent pending bioprocess technology
Molecular Devices has global leadership in the scale-up and industrial manufacture of human-derived 3D organoids using our proprietary bioreactor and patent pending bioprocess technology. Organoids offer significant benefits over 2D monolayer cultures as a research platform, as they can recapitulate the architecture, physiology, and underlying genetic signature of primary tissues.
Organoids can model complex in vivo processes in vitro. Using human materials, such as Patient-Derived Organoids (PDOs), earlier in research and development provides biotech and pharma with patient-centric models that give more applicable results, potentially enabling a reduction in the use of animals and animal tissues.